|
3.1.1 Tabac - e-cigs
|
|
|
|
|
FDA Warns Stores in Crackdown on E-Cigarette Sales to Minors [Bloomberg]
|
|
|
|
|
|
High
school students’ use of e-cigarettes rose more than 10-fold between
2011 and 2015, according to data from the FDA and the Centers for
Disease Control and Prevention. Strict FDA regulations went into effect
Aug. 8 on sales of tobacco products to minors that require retailers to
check for a government ID for anyone under 27.
|
|
|
|
|
|
|
3.7 Alcool
|
|
|
|
4.11 Dép., diag. & prono. - Ovaire
|
|
|
|
4.7 Dép., diag. & prono. - Col de l'utérus
|
|
|
|
|
|
5. Traitements
|
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
The Numbers behind the ProtecT Trial [ACS]
|
|
|
|
|
|
This
week’s release of the first study comparing outcomes between surgery,
radiation, and active surveillance got a lot of buzz. But even then,
some pretty important details did not get as much coverage as they
probably could, and maybe even should have.
|
|
|
|
|
|
|
|
5.12 Immunothérapies
|
|
|
The gamma delta T cell gambit inspires a small London biotech startup with big ideas [EndPoints]
|
|
|
|
|
|
If
you run through the whole gamut of cell therapies being worked on in
cancer research these days, gamma delta T cells aren’t likely to figure
prominently in your review. But for years now Adrian Hayday, who runs
labs at The Francis Crick Institute and King’s College London, has been
fascinated by their unusual ability to penetrate into tissue, making
them potential therapeutic candidates.
|
|
|
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
Come, Let Us Reason Together [In the Pipeline]
|
|
|
|
|
|
One
classic obstacle is the attitude towards publication. In academia, if
it didn’t get published in a journal, it didn’t happen, whereas in
industry journal publication is more of an “Oh, I guess so” affair.
|
|
|
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
6.1 Observation
|
|
|
|
6.11 Patients
|
|
|
|
6.5 Médecines alternatives
|
|
|
|
6.6 Publications
|
|
|